🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 56400P706 (prev. 56400P201 )
- Market Cap
- Small Cap · $189 Million
- IPO
- 7/28/2004 · $14.00/share
Business: MannKind Corp. is a biopharmaceutical company focused on the discovery and development of therapeutic products for diseases, such as diabetes. The Company's product candidate is AFREZZA, inhaled insulin used to control high blood sugar in adults with type one and type two diabetes and also to improve glycemic control.
Notes: March 3, 2017 -- MannKind Corp. (MNKD) will effect a one-for-five (1-5) reverse split of its common stock . The CUSIP number will change to 56400P706.
Company Contact
- CEO
- Matthew Jonathan Pfeffer
- CFO
- Matthew J. Pfeffer
- Headquarters
- 25134 Rye Canyon Loop, Suite 300, Valencia, CA 91355
- Phone
- 661-775-5300
- Investor Relations
- Matthew J. Pfeffer · 661-775-5300 · ir@mannkindcorp.com